Allarity Therapeutics Inc...

0.84
-0.04 (-4.56%)
At close: Mar 04, 2025, 9:59 AM

Allarity Therapeutics Cash Flow Statement

Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13
Net Income -11.9M -16.06M -26.65M -5.07M -14.4M -2.29M -4.9M -3.68M -1.15M -68.66K -81.19K
Depreciation & Amortization 37K 60K 106K 46K 51K 32.53K 8.7K 278.21K 265.22K n/a n/a
Stock-Based Compensation -71K 1.75M 6.37M 616K 333K 214.06K 2.33M n/a n/a n/a n/a
Other Working Capital 1.19M -6.54M 6.88M 412K -47K -10.43K 221.76K 1.05M 168.15K n/a n/a
Other Non-Cash Items -4.26M -631K -466K -2M 5.6M -2.47M 1.05M -599.35K -424.83K 68.66K 81.19K
Deferred Income Tax 97K -1.61M 20K -1.29M -3.76M n/a n/a n/a n/a n/a n/a
Change in Working Capital 3.35M -328K 5.57M 445K 2.06M 278.19K 164.71K 25.91K -723.36K n/a n/a
Operating Cash Flow -12.74M -16.82M -15.05M -7.25M -10.11M -4.24M -1.34M -3.98M -2.03M n/a n/a
Capital Expenditures n/a -18K n/a -3K -8K -5.68K n/a -77.84K n/a n/a n/a
Acquisitions n/a n/a n/a n/a n/a -108.33K n/a n/a 1.93M n/a n/a
Purchase of Investments n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments n/a n/a n/a n/a 237K n/a n/a n/a n/a n/a n/a
Other Investing Acitivies n/a 809K 1M n/a n/a 1.63M -127.96K -100.9K -259.33K n/a n/a
Investing Cash Flow n/a 791K 1M -3K 229K 1.51M -127.96K -178.74K 1.67M n/a n/a
Debt Repayment -2.65M 1M 969K 2.55M 3.55M n/a n/a n/a n/a n/a n/a
Common Stock Repurchased -6.65M -1.51M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies -3.25M -2.31M 725K -223K -5.9M 2.42M 1.16M 4.31M 3.77M n/a n/a
Financial Cash Flow 10.99M -1.31M 33.82M 6.03M 11.2M 2.42M 1.16M 4.31M 3.77M n/a n/a
Net Cash Flow -1.86M -17.53M 19.26M -1.23M 1.29M -298.65K -1.54M 2.07M n/a n/a n/a
Free Cash Flow -12.74M -16.84M -15.05M -7.25M -10.12M -4.24M -1.34M -4.06M -2.03M n/a n/a